tiprankstipranks
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF)
OTHER OTC:SFOSF
SFOSF
Shanghai Fosun Pharmaceutical (Group) Co
RESEARCH TOOLSreports

Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Revenue

26 Followers
StatisticsMarket CapRevenue

Shanghai Fosun Pharmaceutical (Group) Co Revenue

Shanghai Fosun Pharmaceutical (Group) Co had a revenue of 21.70B in the quarter ending Dec 31, 2025, with 115.02%. This bring the company's revenue in the last twelve months to 41.22B, Decreased 2.74%. In the fiscal year ending Dec 31, 2025, Shanghai Fosun Pharmaceutical (Group) Co had annual revenue of 40.42B with -1.57% growth.
Revenue (ttm)
41.22B
Revenue Growth
―
P/S Ratio
0.24
Revenue/Employee
$996,728
Employees
40,557
Market Cap
$9.63B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
40.42B-642.89M-1.57%
Dec 31, 2024
41.07B-332.34M-0.80%
Dec 31, 2023
41.40B-2.55B-5.81%
Dec 31, 2022
43.95B4.95B+12.68%
Dec 31, 2021
39.01B8.70B+28.70%
Dec 31, 2020
30.31B1.72B+6.02%
Dec 31, 2019
28.59B3.67B+14.72%
Dec 31, 2018
24.92B6.38B+34.45%
Dec 31, 2017
18.53B――